Cell and Gene Therapy Market to Hit US$ 105.83 Billion by 2033 | Major Market Players - Novartis AG, Gilead Sciences, Inc., Bristol Myers Squibb Company

"Cell and Gene Therapy Market size reached US$ 13.90 Billion in 2024 and is expected to reach US$ 105.83 Billion by 2033, growing at a CAGR of 21.5% during the forecast period 2025-2033."

Download your exclusive sample report today(corporate email gets priority access):
https://www.datamintelligence.com/download-sample/cell-and-gene-therapy-market?prasad

DataM Intelligence unveils exclusive insights into the Cell and Gene Therapy Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by identifying high-growth segments and reducing investment risks through actionable forecasts. With in-depth competitive benchmarking, it enables smarter strategies and confident decision-making. Leveraging these insights allows stakeholders to stay ahead of market shifts and maximize returns.

Cell and Gene Therapy Market Major Players:

Novartis AG, Gilead Sciences, Inc., Bristol Myers Squibb Company, Vertex Pharmaceuticals Incorporated, Sarepta Therapeutics, Inc., CSL Behring LLC, Amgen, Inc., Orchard Therapeutics group, Krystal Biotech, Inc., bluebird bio, Inc., and among others. Emer

Find the Right Partner to Accelerate Your Growth Today with Our Latest Report:
https://www.datamintelligence.com/partner-identification-enquiry/cell-and-gene-therapy-market?prasad

United States: Recent Industry Developments

✅ In March 2026, Vertex Pharmaceuticals advanced gene-editing therapies targeting rare genetic diseases, expanding its clinical pipeline. The development focuses on CRISPR-based treatments. Vertex continues strengthening gene therapy innovation.

✅ In February 2026, U.S. FDA approved a new CAR-T cell therapy developed by Bristol Myers Squibb for hematologic cancers. The approval expands treatment options for patients. Bristol Myers Squibb continues leading cell therapy advancements.

✅ In January 2026, Pfizer Inc. expanded manufacturing capabilities for gene therapies to support growing demand and clinical trials. The initiative enhances production scalability. Pfizer continues investing in advanced therapeutics.

✅ In December 2025, Gilead Sciences (Kite Pharma) strengthened its CAR-T therapy portfolio with ongoing clinical advancements and commercialization efforts. The company continues expanding oncology treatment solutions.

Japan: Recent Industry Developments

✅ In March 2026, Takeda Pharmaceutical Company Limited expanded its cell therapy pipeline through strategic collaborations focused on rare diseases. The initiative strengthens its regenerative medicine portfolio. Takeda continues advancing biopharmaceutical innovation.

✅ In February 2026, Astellas Pharma Inc. progressed gene therapy programs targeting neuromuscular disorders through clinical development. The company focuses on precision medicine approaches. Astellas continues expanding advanced therapeutics.

✅ In January 2026, Fujifilm Holdings Corporation expanded cell culture and gene therapy manufacturing capabilities through its life sciences division. The initiative supports global demand. Fujifilm continues strengthening regenerative medicine infrastructure.

✅ In December 2025, Daiichi Sankyo Company, Limited advanced research in gene-based therapies targeting oncology applications. The development supports next-generation treatment strategies. Daiichi Sankyo continues investing in innovation.

Cell and Gene Therapy Market Growth:

The cell and gene therapy market is driven by increasing focus on curative treatments for genetic disorders, cancer, and rare diseases. Technological advancements in gene editing tools such as CRISPR and viral vectors are enhancing therapeutic outcomes. Rising investments in biotechnology and clinical trials are accelerating product development. Regulatory support for breakthrough therapies is encouraging innovation. Additionally, growing adoption of personalized medicine is driving demand for advanced therapies.

Market growth is further supported by partnerships between biotech firms, pharmaceutical companies, and research institutions. Expansion of manufacturing capabilities and contract development organizations is enabling scalability. Increasing success rates of clinical trials are boosting confidence in therapies. Rising awareness of advanced treatment options is encouraging patient adoption. Moreover, continuous innovation in delivery systems and gene editing technologies is driving long-term growth.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/cell-and-gene-therapy-market?prasad

Data-Driven Research Methodology for the Cell and Gene Therapy Market:

Our research process for the Cell and Gene Therapy Market at DataM Intelligence combines rigorous primary and secondary research to ensure accurate and reliable insights. We engage with industry experts, key stakeholders, and validated data sources to capture real-time market dynamics. Advanced analytical tools and proprietary models are applied to forecast trends, competitive landscapes, and growth opportunities. Each report undergoes multi-level validation to deliver actionable intelligence that supports strategic decision-making.

Segment Covered in the Cell and Gene Therapy Market:

➥ By Therapy Type: Cell Therapy, Gene Therapy
➥ By Application: Oncology, Musculoskeletal Conditions, Ophthalmology, Blood Disorders, Immunodeficiency Disorders, Graft-versus-host disease (GVHD), Rare Diseases, Others

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=cell-and-gene-therapy-market?prasad

Benefits You Gain from This Report

➡️Authoritative Market Analysis
The report provides a structured evaluation of current market conditions, including validated drivers, restraints, and emerging opportunities, enabling organizations to align strategies with real market dynamics.

➡️Robust and Transparent Forecasting
Market size estimates and growth projections are developed using proven research methodologies and verified data sources, ensuring consistency, accuracy, and reliability for business planning.

➡️Clear Competitive Intelligence
Gain a comprehensive understanding of key market participants, including their strategic initiatives, product offerings, and positioning, allowing for effective competitive benchmarking and response planning.

➡️Granular Segment Insights
Detailed breakdowns by segment, application, and end-user provide clarity on high-growth areas, helping businesses prioritize investments and target the most profitable opportunities.

➡️Region-Specific Strategic Insights
The report delivers actionable intelligence across major geographies, enabling companies to identify region-specific growth trends, demand patterns, and expansion opportunities.

➡️Decision-Ready Data and Insights
All findings are presented in a structured, easy-to-interpret format, allowing stakeholders to translate data into clear business actions, whether for market entry, expansion, or portfolio optimization.

➡️Opportunity and Risk Assessment
The study highlights key investment pockets while also outlining potential risks and market uncertainties, supporting balanced and informed decision-making.

➡️Customization and Expert Support
Clients have access to tailored insights and direct engagement with analysts to address specific business questions, ensuring the report's relevance to strategic objectives.

Most Frequently Asked Questions in the Cell and Gene Therapy Market Research Industry:

➠ How big is the Cell and Gene Therapy Market in 2026?
➠ What growth opportunities and market challenges do Cell and Gene Therapy market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Cell and Gene Therapy market growth?
➠ Who are the key players in Cell and Gene Therapy Market?

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.